Liebe Besucherinnen und Besucher,
heute ab 15 Uhr feiern wir unser Sommerfest und sind daher nicht erreichbar. Ab morgen sind wir wieder wie gewohnt für Sie da. Wir bitten um Ihr Verständnis – Ihr Team von Sack Fachmedien
Buch, Englisch, 674 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 1191 g
Buch, Englisch, 674 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 1191 g
Reihe: Cancer Drug Discovery and Development
ISBN: 978-1-4419-7357-3
Verlag: Springer
A practical guide to the design, conduction, analysis and reporting of clinical trials with anticancer drugs.
Zielgruppe
Research
Fachgebiete
Weitere Infos & Material
Section 1:
Chapter 1: Basic Biostatistics for the Clinical Trialist
Authors: Elizabeth G. Hill and Elizabeth Garrett-Mayer
Chapter 2: Fundamental Concepts in Clinical Pharmacology
Authors: Daniel L. Gustafson and Erica L. Bradshaw-Pierce
Chapter 3: Bioanalytical Methods in Clinical Drug Development
Authors: Walter J. Loos, Peter de Bruijn, Alex Sparreboom
Section 2
Chapter 1: Preclinical Models for Anticancer Drug Development
Author: Edward Sausville
Section 3
Chapter 1: Phase I Clinical Trials with Anticancer Agents
Authors: Stephen Leong, Justin Call, Alex Adjei, Wells Messersmith
Chapter 2: Phase II Clinical Trials with Anticancer Agents
Authors: Hui Gan, J. Jack Lee, Lillian L. Siu
Chapter 3: Phase III Clinical Trials with Anticancer Agents
Authors: Wendy Parulekar and Daniel J. Sargent
Chapter 4: Pharmacokinetic Studies in Early Anticancer Drug Development
Authors: Sharyn D Baker and Alex Sparreboom
Chapter 5: Pharmacodynamic Studies in Early Phase Drug Development
Authors: D. Ross Camidge, Robert C. Doebele and Antonio Jimeno
Chapter 6: Prediction of Antitumor response
Authors: Yu Shyr and Fred R. Hirsch
Chapter 7: Imaging Studies in Anticancer Drug Development
Author: David Mankoff
Section 4
Chapter 1: Role of the US Food and Drug Administration in Cancer Drug Development
Authors: Ann T. Farrell, Ramzi N. Dagher and Richard Pazdur
Section 5
Chapter 1: Early Clinical Trials with Cytotoxic Agents
Authors: M.J.A. de Jonge and Jaap Verweij
Chapter 2: Challenges and Sucesses in Developing Effective Anti-Angiogenic Agents
Authors: Laura QM Chow and S Gail Eckhardt
Chapter 3: Targeted Therapeutics in Cancer Treatment
Authors: Colin D. Weekes and Manuel Hidalgo
Chapter 4: Cancer Chemoprevention
Authors: Christopher H. Lieu, William N. William Jr., Scott M. Lippman
Chapter 5: Combined Modality Therapy in Cancer Management
Authors: David Raben and Kyle Rusthoven
Chapter 6: Cancer Vaccines
Author: Dan Laheru
Chapter 7: Optimizing the Development of Antibodies as Treatment for Cancer
Authors: Craig P Carden, Hendrik-Tobias Arkenau and JS de Bono
Chapter 8: Oligonucleotide Therapeutics
Authors: Cy A Stein, Britta Hoehn, John Rossi
Chapter 9: Anticancer Drug Development in Pediatric Patients
Authors: Lia Gore and Margaret Macy
Chapter 10: Clinical Trials in Special Populations
Authors: S. Percy Ivy, MD; Merrill J. Egorin, MD; Chris H. Takimoto, MD, PhD; and Jeannette Y. Wick, RPh
Section 6:
Chapter 1. NCI Sponsored Clinical Trials
Author: Janet E. Dancey and Andriana Papaconstantinou
